Botox tested as a remedy for facial flushing
NCT ID NCT02216838
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study investigates whether injections of botulinum toxin A (Botox) can treat persistent facial flushing. In a split-face design, each participant receives Botox on one side of the face and a saline placebo on the other, allowing direct comparison. The trial enrolls 16 adults aged 18 to 65 with ongoing facial flushing and measures changes using a spectrophotometer. As a pilot study, it aims to see if this approach is worth studying further.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
botulinum toxin A (Botox)
What this could lead to
If effective, Botox could offer a new option for people bothered by persistent facial redness.
What could go wrong
This is a very small pilot study with only 16 people, so results may not apply broadly. Botox injections carry risks like bruising or temporary muscle weakness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIAL FLUSHING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern University Feinberg School of Medicine, Department of Dermatology
Chicago, Illinois, 60611, United States